Quote:

---

but I believe they are seeking an outright TOTAL cure

---

The study as outlined will not provide a cure. It will provide the same benefit as 700mg subcutaneously. It looks to be designed as proof of concept for their AAV vector technology.

Quote:

---

They also say a functional cure is devoid of CCR5

---

A functional cure is not the same as a cure. In a functional cure the virus still exists in the body and can relapse into full blown HIV.

Quote:

---

It is because they want what you have said PLUS they want to eradicate the reservoir which our current solution does not do.

---

That says nothing about eliminating the reservoir and simple CCR5 blockade will not do so with one possible exception. 3 years ago when I was first looking at leronlimab and HIV I proposed that with a 44 month half life for reservoir monocytes that over an extended period of time (15+ years) and with 100% RO for the entire time that it may be possible to effectuate a cure.

It is why I wanted to know what the level of viral load was over time. That was never released. We do know that the lowest viral load achieved was 1/2 copy per milliliter. If a pattern exists that trended towards a continuing drop in viral load then it bolsters my theory.